Skip to main content

Table 3 Value of lncRNA-ANRIL single detection, SOX9 single detection, and the combined detection for the early diagnosis of glioma

From: Serum lncRNA-ANRIL and SOX9 expression levels in glioma patients and their relationship with poor prognosis

  lncRNA-ANRIL SOX9 Combined detection
Cut-off 2.018 0.395 0.388
Sensitivity (%) 61.97 69.72 81.62
Specificity (%) 96.67 85.00 90.83
AUC 0.860 0.857 0.930
95%CI 91.69–99.08% 77.33–90.86% 84.19–95.33%
Std. error 0.023 0.022 0.016
P <0.001 <0.001 <0.001